Hormetic Response Mechanisms Hormesis describes the biological phenomenon where low doses of a stressor produce beneficial adaptive responses while higher doses become harmful
Weight gain in women at midlife: a concise review of the pathophysiology and strategies for management
Despite significant evidence of improvement in some ASD symptom scales, particularly associated with the use of SFN, L-carnosine and NAC, there is still a lack of evidence and a high risk of bias to justify the use of antioxidant therapies as monotherapy in individuals with ASD
GLP-1 improves endothelial function by enhancing nitric oxide bioavailability and reducing oxidative stress, maintaining vascular health and preventing atherosclerotic changes
Ipamorelin: selective GHS-R1a agonist minimal cortisol, prolactin, or appetite effects GHRP-6: GHS-R1a agonist with additional CRH/ACTH activation, prolactin release, and potent orexigenic activity Ipamorelin selectivity ratio (GH:cortisol) is among the highest of all synthetic GHRPs GHRP-6 was instrumental in GHS-R1a receptor identification but is pharmacologically non-selective GH Release Profiles & Pulse Amplitude Both ipamorelin and GHRP-6 stimulate pulsatile GH release from anterior pituitary somatotrophs via GHS-R1a activation, working synergistically with endogenous GHRH
